- A group of scientists at Sanford Burnham Prebys Medical Discovery Institute have gained new insights into how the virus exploits the human cells it invades.
- The team of researchers are led by Sumit K. Chanda, professor and director of the Immunity and Pathogenesis Programme.
- Check out the latest news and updates on Business Insider.
A team of US scientists, led by an Indian-origin researcher, has identified a set of human genes that fight SARS-CoV-2 infection, the virus that causes Covid-19.
According to Sumit K. Chanda, professor and director of the Immunity and Pathogenesis Programme at Sanford Burnham Prebys Medical Discovery Institute, the scientists have gained new insights into how the virus exploits the human cells it invades.
"We are still searching for its Achille's Heel so that we can develop optimal antivirals," Chanda said in a paper published in the journal Molecular Cell.
Knowing which genes help control viral infection can greatly assist researchers' understanding of factors that affect disease severity and also suggest possible therapeutic options.
The genes in question are related to interferons, the body's frontline virus fighters.
Soon after the start of the pandemic, clinicians found that a weak interferon response to SARS-CoV-2 infection resulted in some of the more severe cases of Covid-19.
This knowledge led Chanda and his collaborators to search for the human genes that are triggered by interferons, known as interferon-stimulated genes (ISGs), which act to limit SARS-CoV-2 infection.
"We found that 65 ISGs controlled SARS-CoV-2 infection, including some that inhibited the virus' ability to enter cells, some that suppressed manufacture of the RNA that is the virus's lifeblood, and a cluster of genes that inhibited assembly of the virus," Chanda explained.
"What was also of great interest was the fact that some of the ISGs exhibited control across unrelated viruses, such as seasonal flu, West Nile and HIV, which leads to AIDS".
The team also identified eight ISGs that inhibited both SARS-CoV-1 and CoV-2 replication in the subcellular compartment responsible for protein packaging, suggesting this vulnerable site could be exploited to clear viral infection.
"This is important information, but we still need to learn more about the biology of the virus and investigate if genetic variability within these ISGs correlates with Covid-19 severity," said Laura Martin-Sancho, a senior postdoctoral associate in the Chanda lab.
As a next step, the researchers will look at the biology of SARS-CoV-2 variants that continue to evolve and threaten vaccine efficacy.
SEE ALSO:Facebook’s Oversight Board has over 9,000 responses in the case related to Donald Trump’s suspension from the platform— a decision is coming soonThousands of IGCSE students are anxiously awaiting clarity on board exams set to start on April 27How to bake a meteorite — scientists are heating up space rocks to recreate the birth of planets
Next Story
I spent $2,000 for 7 nights in a 179-square-foot room on one of the world's largest cruise ships. Take a look inside my cabin.
One of the world's only 5-star airlines seems to be considering asking business-class passengers to bring their own cutlery
Vodafone Idea FPO allotment – How to check allotment, GMP and more
RCRS Innovations files draft papers with NSE Emerge to raise funds via IPO
India leads in GenAI adoption, investment trends likely to rise in coming years: Report
Reliance Jio emerges as World's largest mobile operator in data traffic, surpassing China mobile
Satellite monitoring shows large expansion in 27% identified glacial lakes in Himalayas: ISRO
Vodafone Idea shares jump nearly 8%
